IMV Reports Update on COVID-19 Vaccine Program - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women s Health
[December 28, 2020]
Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women s Health
Myovant and Pfizer to jointly develop and commercialize ORGOVYXâ¢
 (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and Canada
Myovant to receive an upfront payment of $650 million in addition to potential regulatory and sales milestones for a total payment of up to $4.2 billion
Myovant to host conference call and webcast today at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time
BASEL, Switzerland and NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced a collaboration to develop and commercialize relugolix â a once-daily, oral gonadotropin-releasing hormone (GnRH) receptor antagonist â in oncology and
Vuzix Next Generation Smart Glasses Captures 3 CES 2021 Innovation Awards for Outstanding Design and Engineering
News provided by
Share this article
Share this article
ROCHESTER, N.Y., Dec. 28, 2020 /PRNewswire/ Vuzix® Corporation (NASDAQ: VUZI), ( Vuzix or, the Company ), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that Vuzix Next Generation Smart Glasses (NGSG) has received multiple CES 2021 Innovation Awards in recognition of its outstanding design and engineering. Vuzix Next Generation Smart Glasses has received CES 2021 awards in three categories: Computer Peripherals & Accessories, Portable Media Players & Accessories and Wearable Technologies. The CES Innovation Awards is an annual competition honoring outstanding design and engineering in consumer technology products.
AeroCentury Corp. Listing Standards Compliance Update
BURLINGAME, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) After the receipt on September 11, 2020 of a deficiency letter from NYSE American LLC (the “NYSE American”) notifying AeroCentury Corp. (the “Company”) of its non-compliance with the NYSE American’s stockholders’ equity listing standards as set forth in Section 1003(a)(i) – (iii) of the NYSE American Company Guide, the Company submitted a plan to the NYSE American to bring the Company into compliance with such listing standards within 18 months of receipt of the deficiency letter, as disclosed in its report on Form 8-K filed with the United States Securities and Exchange Commission (the “SEC”) on September 16, 2020. On November 25, 2020, the Company received a letter from the NYSE American notifying the Company of its acceptance of the Company’s plan and continuing the Company’s listing pursuant to an extension with a target completion date of March 11, 20
Mytheresa Plans to Raise Up to $150 Million in IPO Samantha McDonald
Mytheresa is gearing up to go public.
The Germany-based online luxury marketplace’s parent, MYT Netherlands Parent B.V., announced today that it has publicly filed a registration statement on Form F-1 with the United States Securities and Exchange Commission. The filing is related to the proposed initial public offering of American Depositary Shares representing its ordinary shares.
More from Footwear News
The company shared that its proposed maximum aggregate offering price is $150 million. It plans to list on the New York Stock Exchange under the symbol “MYTE.”
In a statement accompanying the filing, CEO Michael Kliger reported that Mytheresa surpassed 486,000 active customers, generated 449.5 million euros (or $548.87 million at current exchange) in sales and shipped more than 1.09 million orders to 133 countries during the 2020 fiscal year.